Skip to main content
SpringerLink
Log in

Communicating Therapeutic Risks

  • Book
  • © 1990

Overview

Authors:
  1. Louis A. Morris

    1. Food and Drug Administration, The American University, Gaithersburg, USA

    View author publications

    You can also search for this author in PubMed   Google Scholar

Part of the book series: Recent Research in Psychology (PSYCHOLOGY)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (7 chapters)

  1. Front Matter

    Pages i-xii
    Download chapter PDF

  2. Introduction

    • Louis A. Morris
    Pages 1-8

  3. Learning About Therapy

    • Louis A. Morris
    Pages 9-37

  4. Physician’s Risk Disclosure

    • Louis A. Morris
    Pages 39-61

  5. Patient Information Processing

    • Louis A. Morris
    Pages 63-84

  6. Patients’ Medical Judgments

    • Louis A. Morris
    Pages 85-108

  7. Effects of Risk Communication

    • Louis A. Morris
    Pages 109-132

  8. Mass Media Risk Communication

    • Louis A. Morris
    Pages 133-158

  9. Back Matter

    Pages 159-186
    Download chapter PDF
Back to top

Keywords

About this book

I guess everyone has a cousin Ernest. He is the fellow of whom your mother asks . . . "Why can't you be more like your cousin Ernest?" Cousin Ernest went to the high school for genius children and got all A's, even in French. As the years went by, I lost contact with Cousin Ernest. Then last year, at a family gathering, I met him again. Sure enough, he had gone to Harvard and become a doctor, a radiologist. We began discussing his practice and he mentioned that he performs some fairly risky diagnostic tests. While legally he was compelled to tell patients about the risks they were undertaking, he said that risk disclosure was a useless exercise. "No one has ever refused to undergo the procedure," he said. It was difficult to argue with his observation that no patient ever refused to undergo his tests. I understood that the lack of refusals did not necessarily mean that risk disclosure was a useless exercise, but his underlying argument was quite compelling.

Authors and Affiliations

  • Food and Drug Administration, The American University, Gaithersburg, USA

    Louis A. Morris

Bibliographic Information

  • Book Title: Communicating Therapeutic Risks

  • Authors: Louis A. Morris

  • Series Title: Recent Research in Psychology

  • DOI: https://doi.org/10.1007/978-1-4612-3354-1

  • Publisher: Springer New York, NY

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer-Verlag New York Inc. 1990

  • Softcover ISBN: 978-0-387-97192-6Published: 21 December 1989

  • eBook ISBN: 978-1-4612-3354-1Published: 06 December 2012

  • Series ISSN: 1431-7532

  • Edition Number: 1

  • Number of Pages: XII, 186

  • Topics: Psychology, general

Publish with us

Policies and ethics

Back to top

Search

Navigation